Navigation Links
JNCI news brief: STD confirmed to be associated with increased risk of prostate cancer
Date:9/9/2009

Researchers confirmed previous findings that the sexual transmitted infection known as Trichomonas vaginalis is associated with an increased risk of prostate cancer in a study published online September 9 in the Journal of the National Cancer Institute.

Jennifer Rider Stark, ScD, of the department of epidemiology at the Harvard School of Public Health in Boston, and colleagues conducted a case-control study nested within the Physicians' Health Study that included 673 case subjects with prostate cancer and 673 individually matched control subjects. Plasma was assayed for antibodies against T. vaginalis. The relationship of incident prostate cancer, extraprostatic prostate cancer, and cancer predicted to progress to bony metastases or prostate cancerspecific death was investigated.

Although not statistically significant, the size of the association between T. vaginalisseropositive status and overall prostate cancer risk was similar to that reported previously. A seropositive status was associated with statistically significantly increased risks of extraprostatic prostate cancer and cancer that is likely to progress to bony metastases or prostate cancerspecific death.

"If our findings are confirmed, T. vaginalis could serve as a marker for adverse outcomes in patients for prostate cancer or, more optimistically as a target for secondary chemoprevention," the authors write.

In an accompanying editorial, Peter C. Albertsen, M.D., of the University of Connecticut Health Center, in Farmington, Conn., said that this study is another example of assessing a specific variable to determine the risk of prostate cancer that deserves serious attention.

"Unfortunately, an unintended consequence of prostate-antigen testing is the large number of men diagnosed with incidental disease that now confounds our ability to identify potential causes of clinically significant disease," writes the editorialist, who also p
'/>"/>

Contact: Steve Graff
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. JNCI news brief: Melanosome dynamics and sensitivity of melanoma cells to chemotherapy
2. JNCI news brief: Surgeon training found effective in breast cancer sentinel lymph node trial
3. JNCI news brief: High serum insulin levels and risk of prostate cancer
4. JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
5. JNCI news brief: Breast cancer hormone receptor status and risk of a second primary tumor
6. JNCI news brief: Hepatitis B virus mutations may predict risk of liver cancer
7. JNCI news brief: Improving the biomarker pipeline for early cancer detection
8. In brief: New prognostic indicator for patients with IPF
9. Asymchem Announces Fall Process Symposium Confirmed List of Speakers
10. Medifast Independent Director Lt. Gen. Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs
11. Link between migraines and reduced breast cancer risk confirmed in follow-up study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... February 28, 2015 Vancouver personal injury lawyers ... claims are affected by time limits. They stated that in ... person’s claim or even nullify it. Many a time, delays ... a client’s rights under BC law. As a result, experts ... by accidents should consult a personal injury lawyer in order ...
(Date:2/28/2015)... For those people who are unable to ... Applied Research Foundation (Meso Foundation) will broadcast its ... at 9:30 AM. , The live broadcast is free ... be accessed through any browser on a computer or ... is a unique event that covers important treatment information ...
(Date:2/28/2015)... 2015 National Sales Solutions ... marketing and supply chain management for consumer packaged ... bringing its award winning solutions for thinning-damaged hair ... are specifically created to combat thinning-damaged hair. ... committed to marrying science with nature to create ...
(Date:2/28/2015)... 28, 2015 A case management conference ... that have been filed by law firms including Bernstein ... in March, the Firm notes. , According to ... in the federal litigation will meet on March 13, ... prescription therapy treatments designed to raise levels of the ...
(Date:2/28/2015)... On Thursday, February 26th, Forbes published an article titled ... Steal Your Data , which stresses the ease with which ... phishing kit, or any kind of malware kit for that ... about how everyone’s cyber security is intertwined when it covers ... content management systems or blogs in order to install the ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4
... Encision Inc. (Amex:,ECI), a medical device company owning patented ... in minimally-invasive surgery, reported its,financial results for its third ... for the third quarter of fiscal year 2008, ended ... over net sales of,$2.79 million for the prior fiscal ...
... pro forma adjusted results include 16 percent sales growth and EPS of ... $.90, - Full-year results highlighted ... ... LLY ) today announced financial results for the fourth quarter and,full year of 2007., Throughout this ...
... MS -- Cold and flu season is upon us,affecting ... according to,the Centers for Disease Control. A cold is ... children and the elderly. Early detection,is key, especially since ... the infection,s onset., (Photo: http://www.newscom.com/cgi-bin/prnh/20080129/NYTUFNS1 ), ...
... American Academy,of Family Physicians is pleased that President Bush,s ... access to health care. In doing,so, the president has ... Improving Americans, ability to pay for health care is ... provides care to all, ensures the,financial viability of those ...
... Diet offers cholesterol lowering solution, SAN FRANCISCO, Jan. ... nurse practitioner in San Francisco, has been,helping patients lower ... focusing on the Apo E gene and advanced cholesterol ... disease," insists McDonald, "and it,doesn,t necessarily require a statin ...
... PROGRESS OF HEALTH REFORM IN CALIFORNIA, LOS ANGELES, ... CEO of The California Endowment, today issued the following ... achieving comprehensive health reform took a decidedly,disappointing step backward ... take action on the health reform package known as ...
Cached Medicine News:Health News:Encision Reports Third Fiscal Quarter Results 2Health News:Encision Reports Third Fiscal Quarter Results 3Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 2Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 3Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 4Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 5Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 6Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 7Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 8Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 9Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 10Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 11Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 12Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 13Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 14Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 15Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 16Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 17Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 18Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 19Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 20Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 21Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 22Health News:Flu and Fever Detection Facts for Dr. Mom 2Health News:Flu and Fever Detection Facts for Dr. Mom 3Health News:AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform 2Health News:AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform 3Health News:New Gene-Based Therapy an Alternative to Vytorin and Statins in Heart Disease Prevention and Treatment 2
(Date:2/27/2015)... -- Report Details   Translational ... progress, and predicted revenues ,Where is the market for ... prospects for this market and related technologies? Visiongain,s brand ... to 2025, discussing data, opportunities and prospects. ... medicine : cell-based therapies that aim to restore function ...
(Date:2/27/2015)... Pa. , Feb. 27, 2015  In recognition ... ongoing commitment to the global bleeding disorders community, ... 2 million international units (IUs) of protein therapies to ... international not-for- profit organization which has worked to improve ... bleeding disorders. The donation supports the WFH,s Global Alliance ...
(Date:2/27/2015)...  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... for the fourth quarter and full year ended December ... year for PTC. We are now a growing commercial-stage ... in the rare disease space," stated Stuart W. Peltz, ... proud to bring the first treatment for Duchenne muscular ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11
... Jan. 31, 2012 Halozyme Therapeutics, Inc. (NASDAQ: ... Phase 1 proof-of-concept and local tolerability study of HTI-501 ... 8th World Congress of the International Academy of Cosmetic ... commencement of the Phase 2 portion of the clinical ...
... LAKES, N.J., Jan. 31, 2012 The Board of Directors of ... declared a quarterly dividend of 45 cents per common share, payable ... 2012. The indicated annual dividend rate is $1.80 per share. ... is a leading global medical technology company that develops, manufactures and ...
Cached Medicine Technology:HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial 2HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial 3
BRAT 2 Autologous Blood Recovery System gives performance, speed, versatility, and quality processing. , ,The BRAT 2 is now available with on-board Vacuum, programmability, plasma sequestration, Data...
... Like other blood salvage devices, the ... blood cells lost during and after surgery, ... its kind designed specifically to adapt to ... surgical patients. The system consists of single-patient ...
... Davol® pulsed lavage ... needed for quick, efficient ... bacteria, and foreign material. ... for optimal cleansing and ...
Stryker Instruments InterPulse System advances the ease and performance of battery powered irrigation for Orthopaedics, Trauma, and Wound Care....
Medicine Products: